Amicus Therapeutics, Inc.
FOLD
$7.61
$0.010.13%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 231.00M | 250.57M | 249.95M | 249.76M | 260.06M |
| Total Receivables | 105.85M | 88.32M | 101.10M | 98.07M | 85.17M |
| Inventory | 154.88M | 132.41M | 118.78M | 115.34M | 81.32M |
| Prepaid Expenses | 46.29M | 39.49M | 34.91M | 35.31M | 35.15M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 538.01M | 510.80M | 504.74M | 498.47M | 461.70M |
|
|
|||||
| Total Current Assets | 538.01M | 510.80M | 504.74M | 498.47M | 461.70M |
| Net Property, Plant & Equipment | 50.56M | 50.86M | 51.66M | 53.58M | 53.77M |
| Long-term Investments | 197.80M | 197.80M | 197.80M | 197.80M | 197.80M |
| Goodwill | 197.80M | 197.80M | 197.80M | 197.80M | 197.80M |
| Total Other Intangibles | 15.57M | 16.39M | 17.20M | 18.03M | 18.85M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 13.37M | 14.00M | 13.64M | 18.68M | 17.36M |
| Total Assets | 815.30M | 789.84M | 785.03M | 786.56M | 749.48M |
|
|
|||||
| Total Accounts Payable | 13.89M | 14.45M | 12.95M | 13.48M | 32.06M |
| Total Accrued Expenses | 145.14M | 129.88M | 100.49M | 132.89M | 125.64M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.61M | 8.56M | 8.46M | 8.54M | 8.11M |
| Total Finance Division Other Current Liabilities | -- | -- | 26.81M | 3.23M | 2.26M |
| Total Other Current Liabilities | -- | -- | 26.81M | 3.23M | 2.26M |
| Total Current Liabilities | 167.65M | 152.89M | 148.70M | 158.14M | 168.07M |
|
|
|||||
| Total Current Liabilities | 167.65M | 152.89M | 148.70M | 158.14M | 168.07M |
| Long-Term Debt | 391.32M | 390.71M | 390.11M | 389.49M | 388.94M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 43.38M | 44.20M | 45.08M | 46.62M | 47.01M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 8.65M | 8.49M | 7.10M | 13.48M | 12.95M |
| Total Liabilities | 611.00M | 596.28M | 590.99M | 607.73M | 616.96M |
|
|
|||||
| Common Stock & APIC | 2.96B | 2.94B | 2.93B | 2.91B | 2.87B |
| Retained Earnings | -2.79B | -2.76B | -2.74B | -2.75B | -2.75B |
| Treasury Stock & Other | 30.74M | 12.74M | 5.17M | 25.04M | 8.87M |
| Total Common Equity | 204.30M | 193.56M | 194.05M | 178.83M | 132.52M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 204.30M | 193.56M | 194.05M | 178.83M | 132.52M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 204.30M | 193.56M | 194.05M | 178.83M | 132.52M |
|
|
|||||